After studying burn victims and war veterans, entrepreneur Ran Ma hand-made a sock that contained sensors to detect foot ...

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Mediwound (MDWD – Research Report). The associated price target ...

Hyperbaric Oxygen Therapy HBOT has been a topic of growing interest among healthcare professionals athletes and individuals seeking innovative ways to enhance recovery By placing patients in a pressur ...

MolecuLight Inc., a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load ...

Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Mediwound (MDWD – Research Report) and keeping the price target ...

GIZO Hospital has issued a public reminder to all patients of Non-Communicable Diseases (NCDs), particularly those with ...

TSXV:HEM) Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in Cash ...

Strategic financing will enable MolecuLight to further accelerate commercialization PITTSBURGH, Jan. 6, 2025 /PRNewswire/ -- ...

"This award recognizes MedicosBiotech's innovative fusion of AI and biotechnology," said Soon Cheol Daniel Kim, COO of ...

Advanced wound dressings (for example, alginate, film, foam, hydrocolloid and hydrogel dressings) regulate the wound surface by retaining moisture or absorbing exudate, so protecting the wound base ...

Future Outlook Projection: The research concludes with a forward-looking objective, projecting the future outlook of the industry. This involves synthesizing insights gained throughout the analysis to ...

IMC-2032 is under clinical development by ImmuneCyte and currently in Phase I for Premature Ageing. According to GlobalData, Phase I drugs for Premature Ageing does not have sufficient historical data ...